Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationHematopoietic Stem CellsBone and BonesHematopoietic SystemHematopoiesisLeukemiaHematopoietic Stem Cell TransplantationAnemia, AplasticTransplantation ConditioningLiver TransplantationTransplantation ChimeraTissue DonorsGraft SurvivalBusulfanBone Marrow PurgingHistocompatibility TestingHistocompatibilityCyclophosphamideMice, Inbred C57BLTransplantation, IsogeneicBone Marrow DiseasesKidney TransplantationRecurrenceCombined Modality TherapyColony-Forming Units AssayRadiation ChimeraLeukemia, MyeloidLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBone Marrow ExaminationLeukemia, Myeloid, AcuteSpleenImmunosuppressive AgentsRemission InductionHematologic NeoplasmsTreatment OutcomeGraft RejectionHepatic Veno-Occlusive DiseasePrecursor Cell Lymphoblastic Leukemia-LymphomaBone RemodelingTime FactorsBone Marrow NeoplasmsTransplantation ImmunologyGraft vs Host ReactionCell DifferentiationT-LymphocytesImmunosuppressionLymphocyte DepletionStem Cell TransplantationLeukocyte TransfusionLymphoma, Non-HodgkinHeart TransplantationAcute DiseaseSevere Combined ImmunodeficiencyChimeraHLA AntigensSurvival AnalysisMyelodysplastic SyndromesRetrospective StudiesLung TransplantationFlow CytometryCyclosporineActuarial AnalysisBone DensityHematologic DiseasesLymphocyte TransfusionAntigens, CD34Mice, Inbred BALB CCells, CulturedNuclear FamilyThymus GlandAntineoplastic Combined Chemotherapy ProtocolsCarmustineOrgan TransplantationPancytopeniaGraft vs Tumor EffectCell LineageGraft vs Leukemia EffectFollow-Up StudiesMice, KnockoutCytarabineLeukocyte CountSurvival RateHematopoiesis, ExtramedullaryCytomegalovirus InfectionsMyelolipomaBone ResorptionGranulocyte Colony-Stimulating FactorMelphalanDisease-Free SurvivalEtoposideMice, TransgenicLymphomaMultiple MyelomaVascular Endothelial Growth Factor, Endocrine-Gland-Derived